Human IgG antibody Laboratories manufactures the fence post spikes uk reagents distributed by Genprice. The Fence Post Spikes Uk reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike S. Other Fence products are available in stock. Specificity: Fence Category: Post Group: Spikes Uk
CORD-UK AJ Spare Parts and Accessories |
|
BRADY NV |
Piece of 1 Piece(s) |
EUR 9.44 |
|
Description: Description Dutch: Stroomkabel; Description French: Câble électrique |
MC11 UK AJ Spare Parts and Accessories |
|
BRADY NV |
Pack of 1 Piece(s) |
EUR 450.45 |
|
Description: Description Dutch: MC-11 Elektrische labelopwikkelaar voor het Verenigd Koninkrijk; Description French: Enrouleur d’étiquettes MC-11 pour le Royaume-Uni |
LD100RS UK AJ Spare Parts and Accessories |
|
BRADY NV |
Pack of 1 Piece(s) |
EUR 593.25 |
|
Description: Description Dutch: LD-100-RS Automatische labeldispenser voor het Verenigd Koninkrijk; Description French: Distributeur automatique d’étiquettes LD-100-RS pour le Royaume-Uni |
Human UK ELISA Kit |
|
Abclonal |
96Tests |
EUR 625.2 |
Human True Insulin ELISA Kit |
|
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human True Insulin ELISA Kit |
|
MyBiosource |
48-Strip-Wells |
EUR 550 |
Spikes Uk information
Recombinant Spike RBD (N501Y) Protein of SARS-CoV-2 UK Variant |
|
MBS434290-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1580 |
SARS-CoV-2 full-length Trimeric Spike Antigen (UK Variant, 1mg) |
|
BSV-COV-PR-67 |
BioServUK |
1mg |
EUR 3792 |
|
Description: SARS-CoV-2 full-length Trimeric Spike Recombinant Protein (UK Variant, >1mg) |
SARS-CoV-2 Spike B.1.1.7 Mutation RBD Domain (UK Variant, 100ug) |
|
BSV-COV-PR-72 |
BioServUK |
100 ug |
EUR 620 |
|
Description: SARS-CoV-2 Spike B.1.1.7 Mutation RBD Domain (UK Variant, 100ug) |
SARS-CoV-2 full-length Trimeric Spike Antigen (UK Variant, 100ug) |
|
BSV-COV-PR-65 |
BioServUK |
100 ug |
EUR 620 |
|
Description: SARS-CoV-2 full-length Trimeric Spike Recombinant Protein (UK Variant, 100ug) |
SARS-CoV-2 full-length Trimeric Spike Antigen (UK Variant, 10mg) |
|
BSV-COV-PR-89 |
BioServUK |
10 mg |
EUR 15168 |
|
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK Variant, 10mg) |
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide |
|
9359P |
ProSci |
0.05 mg |
EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide |
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide |
|
MBS154834-005mg |
MyBiosource |
0.05mg |
EUR 205 |
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide |
|
MBS154834-5x005mg |
MyBiosource |
5x0.05mg |
EUR 900 |
Vaginal Swabs, Human Donor - Post-Coitus |
|
MBS170223-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 100ug) |
|
BSV-COV-PR-79 |
BioServUK |
100 ug |
EUR 620 |
|
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 100ug) |
SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 1mg) |
|
BSV-COV-PR-86 |
BioServUK |
1 mg |
EUR 3792 |
|
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 1mg) |
SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 10mg) |
|
BSV-COV-PR-87 |
BioServUK |
10 mg |
EUR 15168 |
|
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 10mg) |
Recombinant RSV Post-fusion glycoprotein F0 |
|
DAG-WT1180 |
Creative Diagnostics |
1 mg |
EUR 1360 |
|
|
|
Description: Recombinant |
SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) Spike S1 (N501Y) Recombinant Protein |
|
11-084 |
ProSci |
0.1 mg |
EUR 651.3 |
|
Description: A new variant of SARS-CoV-2 is spreading in the UK and is rapidly becoming a global threat. It ischaracterized by multiple mutations in the spike protein. Among them, N501Y is of major concernbecause it involves one of the six key amino acid residues determining a tight interaction of theSARS-CoV-2 receptor-binding domain (RBD) with its cellular receptor angiotensin-converting enzyme2 (ACE2). |
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike RBD Recombinant Protein |
|
21-824 |
ProSci |
0.1 mg |
EUR 1186.8 |
|
Description: All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. During the pandemic multiple mutant strains arose. To help the science combat these mutants ProSci offers the RB-Domains of these mutant SPIKE proteins. That is the full RBD domain of the SPIKE surface protein SARS-CoV-2 of the mutant strain B.1.1.7, also commonly known as the "UK / Great Britain mutant". |
OPSN00004-100UG - SARS-CoV-2 Spike RBD N501Y (UK Variant Alpha) Recombinant Protein |
|
OPSN00004-100UG |
Aviva Systems Biology |
100ug |
EUR 370 |
|
|
